Diabetic Peripheral Articles & Analysis

2 news found

PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022

PMC-402 is a TIE2-activating antibody that stabilizes dysfunctional leaky disorganized pathological vessels. Diabetic patients with Diabetic Peripheral Neuropathy will be recruited for Phase I trial. ...

Oct. 18, 2022

ByPharmAbcine Inc.

Nevro Responds to Competitor`s Announcement of FDA Approval for Painful Diabetic Neuropathy

REDWOOD CITY, Calif., Jan. 25, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today responded to Medtronic's announcement of FDA approval for painful diabetic neuropathy (PDN). "PDN represents a very large potential market, and having another competitor validate this large ...

Jan. 25, 2022

ByNevro Corp.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you